MarketCapTrends
VIVS
VivoSim Labs, Inc. (VIVS)
NASDAQ · Healthcare

VivoSim Labs, Inc. Shareholder Equity 2010–2025

VivoSim Labs, Inc. annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • VivoSim Labs, Inc. shareholder equity for the quarter ending March 31, 2025 were 10.5M, a 191.36% increase year-over-year.
  • VivoSim Labs, Inc. shareholder equity for 2025 were 10.5M, a 191.36% increase from 2024.
  • VivoSim Labs, Inc. shareholder equity for 2024 were 3.6M, a 76.51% decrease from 2023.
  • VivoSim Labs, Inc. shareholder equity for 2023 were 15.3M, a 49.26% decrease from 2022.
  • VivoSim Labs, Inc. shareholder equity for 2022 were 30.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
VivoSim Labs, Inc. Annual Shareholder Equity (Millions of US $)
2025$10
2024$4
2023$15
2022$30
2021$39
2020$27
2019$36
2018$45
2017$62
2016$62
2015$49
2014$48
2012$-5
2011$-2
VivoSim Labs, Inc. Quarterly Shareholder Equity (Millions of US $)
2025-03-31$10
2024-03-31$4
2023-03-31$15
2022-03-31$30
2021-03-31$39
2020-03-31$27
2019-03-31$36
2018-03-31$45
2017-03-31$62
2016-03-31$62
2015-03-31$49
2014-03-31$48
2012-12-31$-5
2011-12-31$-2

VivoSim Labs, Inc. Shareholder Equity — FAQ

VivoSim Labs, Inc. (VIVS) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VIVS's shareholder equity history?

The chart and table above show VivoSim Labs, Inc.'s shareholder equity by year and by quarter, including the growth rate.